Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1.04B |
| 2 |
Palo Alto Networks
PANW
|
+$957M |
| 3 |
Medtronic
MDT
|
+$433M |
| 4 |
Pinterest
PINS
|
+$422M |
| 5 |
Colgate-Palmolive
CL
|
+$396M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.38B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$967M |
| 3 |
Apple
AAPL
|
+$847M |
| 4 |
Meta Platforms (Facebook)
META
|
+$700M |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$576M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.9% |
| 2 | Financials | 7.33% |
| 3 | Healthcare | 6.04% |
| 4 | Consumer Discretionary | 5.46% |
| 5 | Communication Services | 3.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
PUT
Pfizer
PFE
$143B
| $24.9M | 0.02% |
+474,400
| New | +$24.2M |
|
627
PPG Industries
PPG
$24.6B
| $24.8M | 0.02% |
217,320
-215,175
| -50% | -$26.9M |
|
628
Arista Networks
ANET
$227B
| $24.7M | 0.02% |
1,055,160
-95,208
| -8% | -$2.61M |
|
629
CALL
Unilever
UL
$137B
| $24.7M | 0.02% |
+478,756
| New | +$24.4M |
|
630
CMS Energy
CMS
$22.6B
| $24.7M | 0.02% |
365,376
-250,817
| -41% | -$17.3M |
|
631
Constellation Energy
CEG
$93.8B
| $24.6M | 0.02% |
428,923
+353
| +0.1% | +$21.2K |
|
632
Tyler Technologies
TYL
$12.7B
| $24.5M | 0.02% |
73,617
+25,459
| +53% | +$9.33M |
|
633
Conagra Brands
CAG
$6.94B
| $24.4M | 0.01% |
713,760
-205,561
| -22% | -$7M |
|
634
Healthcare Realty
HR
$7.28B
| $24.3M | 0.01% |
871,333
+32,815
| +4% | +$974K |
|
635
Extra Space Storage
EXR
$31.3B
| $24.3M | 0.01% |
142,701
-34,122
| -19% | -$6.32M |
|
636
PUT
Devon Energy
DVN
$52.1B
| $24.2M | 0.01% |
+440,000
| New | +$28.7M |
|
637
Ulta Beauty
ULTA
$22B
| $24.2M | 0.01% |
62,703
+5,579
| +10% | +$2.22M |
|
638
Raymond James Financial
RJF
$33.8B
| $24M | 0.01% |
268,841
-86,053
| -24% | -$8.43M |
|
639
Workday
WDAY
$39.6B
| $24M | 0.01% |
171,650
+7,544
| +5% | +$1.37M |
|
640
Entergy
ETR
$50.2B
| $23.9M | 0.01% |
425,146
-105,916
| -20% | -$6.23M |
|
641
AvalonBay Communities
AVB
$26.5B
| $23.9M | 0.01% |
122,952
-24,196
| -16% | -$5.24M |
|
|
MASI
642
DELISTED
Masimo
MASI
| $23.9M | 0.01% |
182,707
+150,239
| +463% | +$20.1M |
|
643
Beyond Meat
BYND
$292M
| $23.8M | 0.01% |
995,365
-82,633
| -8% | -$2.64M |
|
644
Las Vegas Sands
LVS
$31.7B
| $23.8M | 0.01% |
708,308
-177,633
| -20% | -$6.15M |
|
645
Takeda Pharmaceutical
TAK
$54.6B
| $23.7M | 0.01% |
1,686,972
| – | – |
|
646
Viatris
VTRS
$20.4B
| $23.7M | 0.01% |
2,260,120
-916,649
| -29% | -$10M |
|
647
State Street SPDR S&P Metals & Mining ETF
XME
$3.87B
| $23.6M | 0.01% |
544,308
-171,463
| -24% | -$9.31M |
|
|
ANSS
648
DELISTED
Ansys
ANSS
| $23.6M | 0.01% |
98,718
-22,405
| -18% | -$5.93M |
|
649
West Pharmaceutical
WST
$24B
| $23.6M | 0.01% |
78,065
-70,684
| -48% | -$23M |
|
|
PBUG
650
DELISTED
Pacer iPath Gold Trendpilot Exchange-Traded Notes
PBUG
| $23.6M | 0.01% |
+1,000,000
| New | +$24.3M |
|
Similar funds
Barclays's Q2 2022 Portfolio in Review
As of Q2 2022, Barclays held 5,544 positions worth $163B, up 28% from $128B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Barclays deployed $63.1B of net new capital in Q2 2022, opening 561 new positions and adding to 1,332 existing holdings. Its largest new stake was Fisker Inc.: 3,607,227 shares worth $30.9M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.38B trimmed.
- Barclays's largest Q2 2022 buy was Fisker Inc.: 3,607,227 shares worth $30.9M.
- Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q2 2022, an estimated $1.04B increase.
- Barclays's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.38B.
- Barclays fully exited Cerner Corp in Q2 2022, selling an estimated $432M.
- Barclays's ten largest holdings make up 39% of its $163B portfolio in Q2 2022.
- Barclays opened 561 new positions and closed 413 in Q2 2022.
- Barclays's portfolio value rose 28% quarter-over-quarter to $163B.
Based on Barclays's 13F filing for Q2 2022, filed 12 Aug 2022.